Rocket Pharmaceuticals, Inc. SC 13D and SC 13D/A reports

Location
350 Fifth Avenue, Suite 7530, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
6/29/2024, 01:27 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report ROCKET PHARMACEUTICALS, INC. Sep 19, 2023
SC 13D/A Report ROCKET PHARMACEUTICALS, INC. Apr 5, 2023
SC 13D/A Report ROCKET PHARMACEUTICALS, INC. Oct 11, 2022
SC 13D/A Report ROCKET PHARMACEUTICALS, INC. Sep 21, 2022
SC 13D/A Report SC 13D/A Aug 31, 2021
SC 13D/A Report Mar 29, 2021
SC 13D/A Report Jan 8, 2021
SC 13D/A Report Dec 13, 2019
SC 13D/A Report SCHEDULE 13D/A Apr 18, 2019
SC 13D/A Report Nov 29, 2018
SC 13D/A Report ADAGE CAPITAL PARTNERS GP, L.L.C. Jan 19, 2018
SC 13D Report SC 13D Jan 16, 2018
SC 13D/A Report INOTEK PHARMACEUTICALS CORPORATION Oct 26, 2017
SC 13D Report INOTEK PHARMACEUTICALS CORPORATION Oct 5, 2017
SC 13D/A Report SC 13D/A Aug 3, 2017
SC 13D/A Report SC 13D/A Feb 10, 2017
SC 13D/A Report Jan 6, 2017
SC 13D Report SCHEDULE 13D Mar 5, 2015
SC 13D Report SC 13D Mar 5, 2015